Menu
Washingtoner
  • Home
  • Health
  • Technology
  • Financial
  • Artificial Intelligence
  • Business
  • Non-profit
  • Real Estate
  • Concealed Carry
Washingtoner

SafeBreak® Vascular Cleared for Pediatrics
Washingtoner/10219541

Trending...
  • Tacoma: Street Closures Projected to Start August 25 for Residential Street Restoration Program Maintenance Work
  • City of Spokane Receives $1 Million in Wildfire Housing Assistance
  • Food Journal Magazine Focuses Its Los Angeles Dining Coverage Across Three Editorial Verticals
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - Washingtoner -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on Washingtoner
  • Spokane: Male Poses as 'ServPro' Employee in Fire Affected Neighborhood
  • Spokane City Council Members Introduce Tenant Protections
  • Gigasoft 2026 JavaScript Chart Comparison: ProEssentials, Highcharts, SciChart, LightningChart, ECharts
  • Experienced eXp Realty Agent Kerri Lawless Guides Buyers and Sellers Through Life's Next Chapters in St. Tammany Parish
  • Supreme Garage Door Repair Redirects Marketing Dollars Into North Texas Communities

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Haven Treatment Center Surprises Team Member with New Bicycle After Transportation Challenge
  • Kentucky's Plane Crash Data Lands Far from the State's Busiest Airports
  • DBF Viewer 2000 v9.29 Now Supports Batch Field Renaming Across Multiple Files
  • StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
  • Continuous You Foundation Opens Applications For A 100-year Artist Grant
  • Netberg Announces the Aurora X2 Switch Series, Built on Xsight Labs' Programmable X2 Silicon
  • Spokane: Legislative Session Held to Approve Proposed Community Safety Campus
  • Tacoma City Council Adopts Resolution of Intent to Work on Unified Regional Approach to Reduce Homelessness
  • Pete Verbica: America Needs Statesmanship and Common Sense — Not a Cult of Personality
  • Heidi G. Villari of The Villari Firm, PLLC Recognized in The Best Lawyers in America 2027 for Construction Law and Personal Injury Litigation
  • When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
  • Nearly One-Third of CRE Asset Managers Make Major Capital Decisions on Gut Instinct, New Survey Finds
  • RemoteBridge Names Dr. John N. Just, Ed.D. Chief Executive Officer
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History
  • New Analysis Details Three Converging Forces in AI and Workforce Policy Behind a $37 Billion GDP Reduction
  • Revenue Optics Launches Pricing and Revenue Growth Management Practice, Names Shafohi Alamgir Vice President
  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support
  • Diginyze eCommerce ERP Module Creates Single Source of Truth for Enterprise Operations
  • CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards
  • NaturismRE expands international research programme with Health & Wellbeing Survey
_catLbl0 _catLbl1

Popular on Washingtoner

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 539
  • Spokane: SPD Arrest Level III Registered Sex Offender for Failure to Register - 352
  • Tacoma: Applications Now Being Accepted for three Positions on the Urban Design Board - 129
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
  • On the Boards: Proform Builds Announce New Construction in Alki, Seattle
  • Premier Expands Presence with New Bellevue Flexible Workspace Location
  • $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
  • The 'Tax Squeeze': Betsson's Record Quarter Previews the Economics of Finland's 2027 Casino Market
  • K2 Integrity Names Michael Kallabat Global Head of Investigations and Disputes

Similar on Washingtoner

  • Gigasoft 2026 JavaScript Chart Comparison: ProEssentials, Highcharts, SciChart, LightningChart, ECharts
  • RAS AP Consulting Spotlights Managed AP Governance™ at Esker All Access
  • Haven Treatment Center Surprises Team Member with New Bicycle After Transportation Challenge
  • StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
  • Netberg Announces the Aurora X2 Switch Series, Built on Xsight Labs' Programmable X2 Silicon
  • When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
  • Nearly One-Third of CRE Asset Managers Make Major Capital Decisions on Gut Instinct, New Survey Finds
  • RemoteBridge Names Dr. John N. Just, Ed.D. Chief Executive Officer
  • New Analysis Details Three Converging Forces in AI and Workforce Policy Behind a $37 Billion GDP Reduction
  • Revenue Optics Launches Pricing and Revenue Growth Management Practice, Names Shafohi Alamgir Vice President
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute